Alnylam Pharmaceuticals, Inc. Common Stock (NASDAQ: ALNY) last traded at $236.22, up 3.02% on the session. The quote above updates while this page is open; the figures below are drawn from Alnylam Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Alnylam Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ALNY. Its market capitalisation is $31.61 billion.
Valuation measures for Alnylam Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $31.61B |
|---|---|
| Enterprise value | $34.10B |
| P/E ratio | 101.38 |
| Price / sales | 8.51 |
| Price / book | 23.34 |
| Beta | 0.38 |
Trailing-twelve-month figures tagged in Alnylam Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.71B |
|---|---|
| Net income (TTM) | $774.71M |
| EPS (TTM) | $2.33 |
| Operating margin | 13.51% |
| Return on equity | 57.21% |
| Cash | $1.71B |
Range and volume for ALNY over the past 52 weeks.
| 52-week high | $495.55 |
|---|---|
| 52-week low | $197.81 |
| Volume | 1.87M |
| Average volume | 1.69M |
| Previous close | $229.30 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.